Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains

Our plain-English summary of Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains, by F. Zong, E. Fthenou, J. Castro, et al (Cell Proliferation, 2010).

The study

• Authors: F. Zong, E. Fthenou, J. Castro, B. Péterfia, I. Kovalszky, L. Szilák, G. Tzanakakis, K. Dobra
• Journal: Cell Proliferation
• Published: 2010;43(1):29-40
• Cited by: 25 articles, as counted by NIH iCite
• Read it: PubMed · Publisher · Free full text

Abstract

Objectives: Syndecan-1 is a transmembrane proteoglycan involved in various biological processes. Its extracellular, transmembrane and cytoplasmic domains may all participate in signal transduction. The aim of this study was to investigate the biological roles of these domains of syndecan-1.

Materials And Methods: We transfected cells of two mesenchymal tumour cell lines with a full-length syndecan-1 construct and three truncated variants, namely 78 construct lacking the EC domain with exception of DRKE sequence; 77 construct lacking extracellular the whole domain and RMKKK corresponding to a short cytoplasmic motif. Subcellular distribution was revealed using confocal laser microscopy. Overexpression of the constructs was verified using real-time RT-PCR and by FACS analysis and effects of syndecan-1 on cell behaviour were explored. Cell cycle analysis allowed for dissection of mechanisms regulating cell proliferation.

Results: Overexpression of syndecan-1 influenced expression profile of the other syndecan members, and decreased tumour cell proliferation significantly by two mechanisms, as follows: increased length of G0/G1 phase was the most evident change in RMKKK and 77 transfectants, whereas prolonged S phase was more obvious in full-length transfectants. Overexpression of syndecan-1 changed the tumour cell morphology in an epithelioid direction.

Conclusions: Both full-length and truncated syndecan-1 inhibited proliferation of the mesenchymal tumour cells, providing new insights into the importance for cancer growth of different functional domains of this proteoglycan.

In plain English

This was a laboratory study of cultured human tumour cells, not of people, and it did not examine asbestos exposure. The authors used two cell lines of mesenchymal origin: STAV-AB malignant mesothelioma cells and B6FS fibrosarcoma cells. They inserted genes for syndecan-1, a cell-surface protein, either in full-length form or as one of three shortened versions (called 78, 77 and RMKKK). They compared these cells with control cells given an empty vector. The full-length version raised syndecan-1 messenger RNA 5- to 10-fold and syndecan-1 protein 2- to 3-fold. In the mesothelioma cells, syndecan-2 went down at the same time. Most of the altered cells grew more slowly than the controls, and the largest effect was a drop of about 30% in proliferation rate. In the fibrosarcoma cells, the RMKKK and 77 versions mainly lengthened the G0/G1 phase of the cell cycle, while the full-length version mainly lengthened the S phase. The altered fibrosarcoma cells also became less elongated: their length-to-width ratios were 2.21 to 2.32, compared with 2.74 in the controls. The authors concluded that both full-length and shortened syndecan-1 inhibited proliferation of both cell lines.

We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.

What the study did and found

• Design: laboratory (in vitro) cell-culture experiment using gene transfection of human tumour cell lines
• Who was studied: two human tumour cell lines of mesenchymal origin: STAV-AB malignant mesothelioma cells and B6FS fibrosarcoma cells
• Exposure: No asbestos exposure was studied. Cells were transfected with a full-length syndecan-1 construct or with one of three truncated variants (78, 77 and RMKKK), and were compared with cells given an empty EGFP vector.
• Main results:
  • The full-length syndecan-1 construct increased syndecan-1 mRNA 5- to 10-fold compared with EGFP vector control cells.
  • At the protein level, syndecan-1 increased 2- to 3-fold after transfection with the full-length construct.
  • In the mesothelioma cells, syndecan-1 upregulation was accompanied by simultaneous downregulation of syndecan-2.
  • Most transfected cells in both cell lines had longer doubling times than EGFP control cells. The largest effect was a decrease of around 30% in proliferation rate.
  • In the cell cycle analysis of the fibrosarcoma transfectants, prolonged S phase was most evident in full-length transfectants. Increased G0/G1 phase was most evident with the RMKKK and 77 constructs.
  • In the fibrosarcoma cells, the cell length-to-width ratio was 2.21 to 2.32 in the overexpressing cell lines, compared with 2.74 in EGFP control cells.
• The authors' conclusion: The authors concluded that both full-length and truncated syndecan-1 inhibited proliferation of the two malignant tumour cell lines studied, through two different mechanisms related to the size of the constructs.
• Limitations the authors state:
  • The authors noted that syndecan-1 overexpression also changed the levels of other syndecans, so the influence of those other syndecans must be taken into consideration.

Topics

Medical terms in this study, explained in our Lexicon: Epithelioid.

Related studies

• Novel genes and pathways modulated by syndecan-1: implications for the proliferation and cell-cycle regulation of malignant mesothelioma cells — T. Szatmári, F. Mundt, et al. (2012)
• Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma — G. Heidari-Hamedani, R.R. Vivès, et al. (2015)
• Diagnostic and prognostic value of soluble syndecan-1 in pleural malignancies — F. Mundt, G. Heidari-Hamedani, et al. (2014)
• Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma — E.K. Sage, K.K. Kolluri, et al. (2014)
• Functional inhibition of heat shock protein 70 by VER-155008 suppresses pleural mesothelioma cell proliferation via an autophagy mechanism — K. Sakai, M. Inoue, et al. (2021)
• Oxidative stress alters syndecan-1 distribution in lungs with pulmonary fibrosis — C.R. Kliment, J.M. Englert, et al. (2009)

Browse return to medical research.